|
Market Closed -
Xetra
19:35:28 08/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 246.90 EUR | -5.04% |
|
-4.82% | -0.12% |
| 10-08 | AlphaValue's positive view is not enough for Sartorius Stedim Biotech |  |
| 10-06 | Relief in oil and bond markets supports stocks | RE |
Company Valuation: Sartorius AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 37,429 | 24,078 | 20,462 | 13,392 | 15,142 | 15,269 | - | - |
| Change | - | -35.67% | -15.02% | -34.55% | 13.07% | 0.83% | - | - |
| Enterprise Value (EV) 1 | 39,161 | 26,454 | 25,394 | 17,138 | 18,884 | 18,844 | 18,539 | 18,139 |
| Change | - | -32.45% | -4.01% | -32.51% | 10.18% | -0.21% | -1.62% | -2.16% |
| P/E | 127x | 37.2x | 111x | 176x | 110x | 64.9x | 49.5x | 42x |
| PBR | 32.3x | 13.9x | 11x | 5.37x | 6.31x | 5.73x | 5.18x | 4.78x |
| PEG | - | 0x | -1.6x | -3x | 1.3x | 0.9x | 1.6x | 2.3x |
| Capitalization / Revenue | 10.9x | 5.77x | 6.03x | 3.96x | 4.28x | 4.1x | 3.73x | 3.41x |
| EV / Revenue | 11.4x | 6.34x | 7.48x | 5.07x | 5.34x | 5.06x | 4.53x | 4.05x |
| EV / EBITDA | 33.3x | 18.8x | 26.4x | 18.1x | 18x | 16.9x | 14.7x | 12.8x |
| EV / EBIT | 43.4x | 24.8x | 50.4x | 43.7x | 34.8x | 28.4x | 23.5x | 19.8x |
| EV / FCF | 85.4x | 125x | 86.4x | 30.3x | 48.4x | 45.7x | 31.5x | 24.7x |
| FCF Yield | 1.17% | 0.8% | 1.16% | 3.3% | 2.07% | 2.19% | 3.17% | 4.05% |
| Dividend per Share 2 | 1.26 | 1.44 | 0.74 | 0.74 | 0.74 | 0.7978 | 0.9794 | 1.131 |
| Rate of return | 0.21% | 0.39% | 0.22% | 0.34% | 0.3% | 0.32% | 0.4% | 0.46% |
| EPS 2 | 4.67 | 9.92 | 3 | 1.22 | 2.25 | 3.803 | 4.984 | 5.881 |
| Distribution rate | 27% | 14.5% | 24.7% | 60.7% | 32.9% | 21% | 19.6% | 19.2% |
| Net sales 1 | 3,449 | 4,175 | 3,396 | 3,381 | 3,538 | 3,722 | 4,088 | 4,480 |
| EBITDA 1 | 1,175 | 1,410 | 962.7 | 945 | 1,052 | 1,116 | 1,262 | 1,420 |
| EBIT 1 | 903.2 | 1,065 | 503.9 | 392.6 | 542.6 | 664.4 | 787.9 | 917.8 |
| Net income 1 | 318.9 | 678.1 | 205.2 | 84 | 154.9 | 255.2 | 329.7 | 390.7 |
| Net Debt 1 | 1,733 | 2,375 | 4,932 | 3,746 | 3,741 | 3,575 | 3,270 | 2,871 |
| Reference price 2 | 595.20 | 369.40 | 333.20 | 215.20 | 247.20 | 246.90 | 246.90 | 246.90 |
| Nbr of stocks (in thousands) | 68,416 | 68,416 | 68,416 | 69,038 | 69,038 | 69,038 | - | - |
| Announcement Date | 27/01/22 | 26/01/23 | 26/01/24 | 28/01/25 | 03/02/26 | - | - | - |
1EUR in Million2EUR
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 68.57x | 5.29x | 17.65x | 0.31% | 18.04B | |
| 32.9x | 5.76x | 22.06x | 0.28% | 245B | |
| 37.02x | 6.61x | 20.93x | 0.65% | 154B | |
| 44.64x | 11.9x | 26.26x | -.--% | 146B | |
| 15.72x | 3.26x | 10.63x | -.--% | 60.26B | |
| 34.5x | 6.77x | 21.5x | -.--% | 49.44B | |
| 32.93x | 6.52x | 22.13x | 0.61% | 47.67B | |
| 18.96x | 2.31x | 11.7x | 2.66% | 48.04B | |
| 43.25x | 10.48x | 23.1x | -.--% | 45.74B | |
| 76.33x | 7.23x | 22.01x | -.--% | 42.84B | |
| Average | 40.48x | 6.61x | 19.80x | 0.45% | 85.69B | |
| Weighted average by Cap. | 37.23x | 7.01x | 21.12x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- SRT3 Stock
- Valuation Sartorius AG
Select your edition
All financial news and data tailored to specific country editions
